Carbetocin Versus Misoprostol in Cases With Placenta Previa After C.S.

• Status: Recruiting
• Trial end date: 2021-04-01
• Target enrollment: 0
• Participant gender: Female

Summary

We will compare efficacy and safety of Carbetocin with Misoprostol in prevention of postpartum hemorrhage in Placenta previa women after C.S.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Beni-Suef University
• Collaborator: Cairo University
• Treatments: Carbetocin; Misoprostol; Oxytocin

Criteria

Inclusion Criteria:

• Women with a singleton pregnancy undergoing cesarean section after 37 weeks of gestation.

Exclusion Criteria:

• • Women undergoing caesarean section with general anesthesia will be excluded, because carbetocin is licensed for use with regional anaesthesia only.

• women undergoing caesarean section at less than 37 weeks of gestation.

• Hypertension with pregnancy.

• Cardiac and coronary diseases with pregnancy